THE World Health Organisation (WHO) on Monday recommended glycated haemoglobin,or HbA1c,as an additional test to diagnose diabetes mellitus. According to the world health body,the test offers a more practical approach to diagnosing the disease that affects over 220 million people worldwide.
Dr Ala Alwan,Assistant Director General of WHOs Non-communicable Diseases and Mental Health Cluster,says the addition of this test for diagnosing diabetes is a positive development,provided that stringent quality assurance tests are in place and measurements standardised.
Unlike other means of diagnosis,it does not require a patient to fast before a blood sample is taken,nor to consume a glucose drink that many people find unpalatable. HbA1c also has the advantage of reflecting the persons average blood glucose levels over the preceding two-three months, says Dr Alwan.
Even though the test is used in India for monitoring blood sugar levels,experts say for the purpose of diagnosis,further research is needed.